Cardiac Rhythm Management (CRM) Devices And Equipment Market Report 2026

Cardiac Rhythm Management (CRM) Devices And Equipment Market Overview

• Cardiac Rhythm Management (CRM) Devices And Equipment market size has reached to $15.52 billion in 2025 • Expected to grow to $21.22 billion in 2030 at a compound annual growth rate (CAGR) of 5.6% • Growth Driver: Geriatric Population Drives Growth In The Cardiac Rhythm Management (CRM) Devices And Equipment Market • Market Trend: Innovative Leadless Pacemaker Advancing Crm Devices Market • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Cardiac Rhythm Management (CRM) Devices And Equipment Market?

Cardiac rhythm management (CRM) devices and equipment are used to manage the heart rate or rhythm by generating electrical impulses or shocks in order to get the heart back to its normal functions. CRM devices are used to treat and manage arrhythmia-related diseases such as cardiac arrests, heart failure, or cardiac arrhythmias. The main products of cardiac rhythm management devices and equipment are pacemakers, defibrillators, and cardiac resynchronization therapy (CRT). A pacemaker is a small device that's placed in the chest to control the heartbeat. It's used to prevent the heart from beating too slowly. The applications involved are bradycardia, tachycardia, heart failure, and others that are used by various end-users such as hospitals, ambulatory surgical centres, and physician’s clinics.

What Is The Cardiac Rhythm Management (CRM) Devices And Equipment Market Growth Forecast?

The cardiac rhythm management (crm) devices and equipment market size is expected to see strong growth in the next few years. It will grow to $21.22 billion in 2030 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to increasing demand for home-based cardiac monitoring, rising adoption of leadless pacemakers, expansion of heart failure management programs, growing investments in smart CRM platforms, continuous innovation in low-power device electronics. Major trends in the forecast period include increasing adoption of remote cardiac monitoring devices, rising use of miniaturized implantable crm devices, growing integration of ai-based arrhythmia detection, expansion of wireless and leadless technologies, enhanced focus on battery longevity and device safety.

Global Cardiac Rhythm Management (CRM) Devices And Equipment Market Segmentation

1) By Product: Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) 2) By Application: Bradycardia, Tachycardia, Heart Failure, Other Applications 3) By End User: Hospitals, Ambulatory Surgical Centers, Physicians Clinics Subsegments: 1) By Pacemakers: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers, Implantable Pacemakers 2) By Defibrillators: Implantable Cardioverter Defibrillators (ICDs), External Defibrillators, Wearable Defibrillators, Automated External Defibrillators (AEDs) 3) By Cardiac Resynchronization Therapy (CRT): CRT-P (Pacemaker), CRT-D (Defibrillator), Bi-Ventricular Pacemakers

What Are The Drivers Of The Cardiac Rhythm Management (CRM) Devices And Equipment Market?

The rise in the geriatric population is expected to propel the growth of the cardiac rhythm management (CRM) devices and equipment market going forward. The geriatric population refers to people aged 65 and over. With the increase in geriatric population, the incidence of cardiovascular diseases also rises, leading to an increased demand for CRM devices. These devices can help manage heart rhythm disorders, such as arrhythmias, and improve the quality of life for older adults. For instance, according to the Administration for Community Living, a US-based government department, the older population is projected to reach 80.8 million by 2040 and 94.7 million by 2060. Thus, the rise in the geriatric population is driving the growth of the cardiac rhythm management (CRM) devices and equipment industry. The rising incidences of cardiovascular diseases are expected to propel the growth of the cardiac rhythm management (CRM) devices and equipment market going forward. Cardiovascular diseases refer to a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart attacks, strokes, hypertension (high blood pressure), heart failure, and arrhythmias. The rising incidence of cardiovascular diseases is significantly influenced by unhealthy lifestyle choices, including poor dietary habits and a lack of physical activities. Cardiac Rhythm Management (CRM) devices and equipment are essential in diagnosing, monitoring, and treating cardiovascular diseases, particularly those related to abnormal heart rhythms (arrhythmias). For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, up 4.0% from 224.4 per 100,000 in 2023. Therefore, the rising incidences of cardiovascular diseases are driving the growth of the cardiac rhythm management (CRM) devices and equipment industry.

Key Players In The Global Cardiac Rhythm Management (CRM) Devices And Equipment Market

Major companies operating in the cardiac rhythm management (crm) devices and equipment market are Abbott Laboratories, Medtronic plc, Biotronik SE & Co. KG, Cardiac Science Corporation, Schiller AG, Integer Holdings, Philips Healthcare, Röchling Medical, CCC Medical Devices, LivaNova plc, ZOLL Medical Corporation, Koninklijke Philips N.V., Applied Cardiac Systems, MicroPort Scientific Corporation, ReliantHeart Inc., Shree Pacetronix Ltd., Shaanxi Qinming Medical Instrument Co. Ltd., Boston Scientific Corporation, Progetti Srl, Medico S.p.A.

Global Cardiac Rhythm Management (CRM) Devices And Equipment Market Trends and Insights

Major companies operating in the cardiac rhythm management (CRM) devices and equipment market are focusing on developing leadless and next-generation miniature pacemakers, such as dual-chamber leadless systems, to reduce lead-related complications, expand patient eligibility, and improve long-term therapy durability. A dual-chamber/leadless pacemaker system is an implantable pacing solution that provides atrial and ventricular pacing without transvenous leads using two small, self-contained implants that communicate with each other or a single miniaturized device with advanced sensing thereby lowering infection and lead-failure risks while maintaining physiologic pacing. For instance, in July 2023, Abbott, a US-based medical device company, launched commercial implants of the AVEIR DR dual-chamber leadless pacemaker system after FDA approval earlier that year, introducing the first leadless option to treat both atrial and ventricular pacing indications and enabling implant-to-implant communication for coordinated dual-chamber therapy.

Regional Outlook

North America was the largest region in the global cardiac rhythm management (CRM) devices and equipment market in 2025. Western Europe was the second-largest region in the cardiac rhythm management (CRM) devices and equipment market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Cardiac Rhythm Management (CRM) Devices And Equipment Market?

The cardiac rhythm management (CRM) devices and equipment market consist of sales of Pacemakers, (implantable pacemakers, external pacemakers), defibrillators (implantable cardioverter defibrillators, external defibrillators), and cardiac resynchronization therapy (CRT-defibrillators, CRT-pacemakers) that are used for rhythm management. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.